On Purpose with Jay Shetty
Also in Health & Fitness
Health & Fitness
EASL Podcasts
by European Association for the Study of the Liver
Today: #196 in Health & Fitness, India on our combined chart.
Today: #199 in Health & Fitness, Japan on our combined chart.
Share this ranking
Claiming needs an RSS feed. Contact us.
Chart positions today · Japan
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like EASL Podcasts, try…
Katie Austin Workouts
Also in Health & Fitness
Huberman Lab
Also in Health & Fitness
Australian Prescriber Podcast
Similar topics: liver and acute
Core IM | Internal Medicine Podcast
Also in Health & Fitness
Lion's Digest - Advances in Gastroenterology and Hepatology
Also in Health & Fitness
Ranking history · Japan
History builds daily. We started tracking this show on the Health & Fitness, Japan chart recently, so the trend line appears after a second day of data.
View as table
| Date | Combined Rank | Apple Podcasts |
|---|---|---|
| Oct 11 | #199 | #199 |
Latest episodes
-
EASL DeepDive: Key Updates in the EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
October 9, 2026 · 1 hr 6 minThis EASL Deep Dive explores key updates from the EASL Clinical Practice Guidelines on hepatocellular carcinoma (HCC), with a practical focus on diagnosis and treatment selection. Experts will discuss evolving imaging and diagnostic…
-
Resmetirom and Semaglutide in MASH: Who, when and how to monitor?
September 30, 2026 · 43 minThis episode of Talk Liver to Me explores the practical use of resmetirom and semaglutide in MASH, based on the 2026 EASL–EASD–EASO Guidance. Experts discuss who may benefit from treatment, when to initiate therapy, and how to monitor…
-
Talk Liver To Me - Africa’s Liver Crisis: Why Is No One Talking About It?
September 16, 2026 · 41 minLiver disease represents a major and under-recognised public health challenge across Africa, driven by a complex interplay of viral hepatitis, rising metabolic dysfunction-associated steatotic liver disease, and a high burden of…
-
EASL DeepDive: Utility and challenges of genetic testing in PFIC
September 14, 2026 · 1 hr 3 minThis webinar explores the role of genetic testing in diagnosing Progressive Familial Intrahepatic Cholestasis (PFIC). Attendees will review key test types, understand the principles behind modern genomic technologies, and learn how to…
-
Talk Liver To Me - What are the Dos and Don'ts in Acute Liver Failure?
September 2, 2026 · 39 minAcute liver failure (ALF) is a rare but life-threatening condition requiring rapid recognition and decisive management. Early decisions around investigation, escalation, and referral can significantly impact outcomes. Despite advances in…
Show 7 more episodesShow fewer episodes
-
Talk Liver To Me - Endohepatology: Added value or added complexity?
August 19, 2026 · 42 minEndohepatology is emerging as a novel approach to liver disease assessment, with the potential to combine EUS-guided liver biopsy, portal pressure measurement, and variceal evaluation within a single session. This “one-stop shop” model…
-
Talk Liver To Me - What nobody tells you about starting a research group
August 5, 2026 · 33 minEarly-career researchers and clinician-scientists play a central role in advancing hepatology research and innovation, yet the transition to independence often comes with challenges that extend beyond scientific expertise. Building a…
-
Talk Liver To Me - Global Updates on Hepatitis E: How Should We Manage Acute and Chronic Infection?
July 22, 2026 · 47 minHepatitis E is a globally prevalent infection with diverse clinical manifestations, ranging from self-limiting acute hepatitis to chronic infection in immunosuppressed patients. Its presentation and epidemiology vary significantly between…
-
Talk Liver To Me - MASLD and HFpEF: Do We Need a Shared Treatment Strategy?
July 8, 2026 · 39 minMetabolic dysfunction-associated steatotic liver disease (MASLD) and heart failure with preserved ejection fraction (HFpEF) are increasingly recognised as manifestations of a shared cardiometabolic disorder. Driven by overlapping risk…
-
A joint EASL-ERN RARE-LIVER DeepDive – Wilson’s disease: a 2026 update
July 3, 2026 · 1 hr 5 minThe following objectives will be addressed in this EASL Deep Dive episode: Have a profound knowledge of the pitfalls, limitations and difficulty of interpretation of the different tests of copper metabolism and liver copper assessmentsBe…
-
Talk Liver To Me - Chasing the perfect SLD preclinical model
June 24, 2026 · 34 minSteatotic liver disease (SLD) research relies heavily on preclinical models, yet no single model can fully capture the complexity of human disease. In this episode, we explore the new EASL position paper on preclinical SLD models. From…
-
Talk Liver To Me - Haemochromatosis in 2026: Who Needs Testing and Who Needs Treatment?
June 10, 2026 · 43 minHaemochromatosis remains one of the most common inherited metabolic disorders, yet it is frequently underdiagnosed and inconsistently managed in clinical practice. With widespread use of iron studies and genetic testing, clinicians are…
About the show
The EASL Podcast collection brings together Talk Liver to Me, EASL’s exclusive original podcast, alongside educational audio content adapted from EASL Studio, DeepDive webinars, and Policy Dialogues. Stay informed with expert insights, practical discussions, and the latest knowledge in hepatology — anytime, anywhere.